TIMP2 and neuroblastoma: Advanced stages of neuroblastoma show increased expression of the matrix metalloproteinase (MMP-2), and a higher MMP-2 to TIMP-2 ratio has been shown to correlate with poorer prognosis for neuroblastoma patients (5).